Zobrazeno 1 - 10
of 366
pro vyhledávání: '"Kreller, M."'
Autor:
Brühlmann SA; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany., Walther M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. m.walther@hzdr.de., Blei MK; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany., Mamat C; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany., Kopka K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307, Dresden, Germany., Freudenberg R; Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany., Kreller M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Aug 15; Vol. 9 (1), pp. 60. Date of Electronic Publication: 2024 Aug 15.
Autor:
Gordon M; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada; Faculty of Medicine, University of Ottawa. 451 Smyth Rd, Ottawa K1H 8M5, ON, Canada. Electronic address: mgord105@uottawa.ca., Jayakumar N; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada., Atzema C; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada., Korczak DJ; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada; The Hospital for Sick Children, 555 University Ave, Toronto M5G 1X8, ON, Canada., Kennedy S; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada; St. Michael's Hospital. 36 Queen St E, Toronto M5B 1W8, ON, Canada., Schaffer A; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada., Goldstein B; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada; Centre for Addiction and Mental Health. 250 College St, Toronto M5T 1R8, ON, Canada., Orser BA; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada., Yee D; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada., Fiksenbaum L; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada; York University. 4700 Keele St, Toronto M3J 1P3, ON, Canada., Choi LHL; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada., Phillips A; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada., McFarlan A; St. Michael's Hospital. 36 Queen St E, Toronto M5B 1W8, ON, Canada., Kreller M; The Hospital for Sick Children, 555 University Ave, Toronto M5G 1X8, ON, Canada., Freedman C; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada., Tanenbaum B; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada., McDowall D; The Hospital for Sick Children, 555 University Ave, Toronto M5G 1X8, ON, Canada., Ceniti A; St. Michael's Hospital. 36 Queen St E, Toronto M5B 1W8, ON, Canada., Sinyor M; Sunnybrook Health Sciences Centre. 2075 Bayview Ave, Toronto M4N 3M5, ON, Canada; Temerty Faculty of Medicine, University of Toronto. 1 King's College Circle, Toronto M5S 1A8, ON, Canada.
Publikováno v:
Psychiatry research [Psychiatry Res] 2024 Jun; Vol. 336, pp. 115892. Date of Electronic Publication: 2024 Apr 06.
Publikováno v:
61. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin, 19.-22.04.2023, Leipzig, Deutschland
Ziel: Die Herstellung von 6-L-[18F]FDOPA durch elektrophile Radiomarkierung mit [18F]F2 Gas ist eine in Dresden-Rossendorf seit über 20 Jahren praktizierte Methode [1,2]. Mit der Inbetriebnahme eines neuen Zyklotrons TR-Flex und des F2-Gastargets 20
Autor:
Brühlmann SA; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany., Walther M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. m.walther@hzdr.de., Kopka K; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.; Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01062, Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307, Dresden, Germany., Kreller M; Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Jan 05; Vol. 9 (1), pp. 3. Date of Electronic Publication: 2024 Jan 05.
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, B 15 June 2013 305:37-39
Autor:
Brühlmann, S. A., Kreller, M., Pietzsch, H.-J., Kopka, K., Mamat, C., Walther, M., Reissig, F.
Publikováno v:
Pharmaceuticals 15(2022), 1167
Targeted Alpha Therapy is a research field of highest interest in specialized radionuclide therapy. Over the last decades, several alpha-emitting radionuclides have entered and left research topics towards their clinical translation. Especially, 225A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::3e3794f53dc0286153d186eb1612af14
https://www.hzdr.de/publications/Publ-35111-1
https://www.hzdr.de/publications/Publ-35111-1
Publikováno v:
18th Workshop on Targetry and Target Chemistry, 21.-26.08.2022, Whistler, Canada
For the cyclotron-based production of the theranostic radionuclide 67Cu through the 70Zn(p,α)67Cu reaction electroplated metallic Zn and ZnO powder targets are being studied. Highly enriched 70Zn targets were designed and optimized considering nucle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4577::4935f897d4cb7c6faa377140055749e2
https://www.hzdr.de/publications/Publ-36329-1
https://www.hzdr.de/publications/Publ-36329-1
Publikováno v:
20th European Symposium on Radiopharmacy and Radiopharmaceuticals, 24.-27.11.2022, Verona, Italien
Abstracts from the 20th European symposium on radiopharmacy and radiopharmaceuticals, 24.-27.11.2022, Verona, ItalienEJNMMI Radiopharmacy and Chemistry
Abstracts from the 20th European symposium on radiopharmacy and radiopharmaceuticals, 24.-27.11.2022, Verona, ItalienEJNMMI Radiopharmacy and Chemistry
L-[11C]Methionine ([11C]Met) is frequently used for the diagnosis of tumours located in brain, head and neck or for tumours induced by the multiple myeloma. The radio synthesis of [11C]Met commonly starts with [11C]CO2 with subsequent transformation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4750baf217135972bc1736b882cddb08
https://www.hzdr.de/publications/Publ-34888-1
https://www.hzdr.de/publications/Publ-34888-1
Publikováno v:
Fourth international edition of the symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022), 14.-17.09.2022, Brixen, Italien
This project aims to explore the cyclotron-based production of 67Cu through the 70Zn(p,α)67Cu reaction, in contrast to other possible routes (e.g. photonuclear reaction). The reaction features a low yield and the need of expensive target material, t
Cyclotron-Based Production of 67 Cu for Radionuclide Theranostics via the 70 Zn(p,α) 67 Cu Reaction.
Autor:
Brühlmann SA; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Bergstraße 66, 01069 Dresden, Germany., Walther M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Kreller M; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Reissig F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Pietzsch HJ; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Kniess T; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany., Kopka K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany.; School of Science, Faculty of Chemistry and Food Chemistry, Technische Universität Dresden, Bergstraße 66, 01069 Dresden, Germany.; National Center for Tumor Diseases (NCT) Dresden, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Fetscherstraße 74, 01307 Dresden, Germany.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Feb 17; Vol. 16 (2). Date of Electronic Publication: 2023 Feb 17.